Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$9.1 million.

  • Treace Medical Concepts' Cash from Operations rose 2322.24% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year increase of 6252.93%. This contributed to the annual value of -$37.2 million for FY2024, which is 749.67% down from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Cash from Operations is -$9.1 million, which was up 2322.24% from -$3.0 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Cash from Operations registered a high of $4.2 million during Q1 2025, and its lowest value of -$17.3 million during Q1 2023.
  • Over the past 5 years, Treace Medical Concepts' median Cash from Operations value was -$7.2 million (recorded in 2022), while the average stood at -$6.7 million.
  • As far as peak fluctuations go, Treace Medical Concepts' Cash from Operations tumbled by 152354.26% in 2022, and later soared by 15813.6% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Cash from Operations stood at -$3.8 million in 2021, then plummeted by 42.54% to -$5.3 million in 2022, then skyrocketed by 109.95% to $532000.0 in 2023, then plummeted by 890.79% to -$4.2 million in 2024, then crashed by 116.12% to -$9.1 million in 2025.
  • Its Cash from Operations stands at -$9.1 million for Q3 2025, versus -$3.0 million for Q2 2025 and $4.2 million for Q1 2025.